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P-25-019 The differences of cognitive deficits in chronic
schizophrenia on long-term treatment with typical and
atypical antipsychotics
M. Han1, X.-F. Huang2, X. Y. Zhang3. 1University of Wollongong,
Wollongong, Australia; 2University of Wollongong, Schizophrenia Research
Institute, Wollongong, Australia; 3Baylor College of Medicine, Beijing
HuiLongGuan Hospital, Houston, USA
Objective: Cognitive deficits have been presented in the prior to the onset
of other symptoms of schizophrenia and generally persisted during the
course of the disease. Whether cognitive function is affects by antipsycho-
tic treatment during the course of schizophrenia is still debated. This
study aimed to examine the effect of long-term treatment of antipsychotic
drugs on cognitive function in patients with chronic schizophrenia.
Methods: The study assessed cognitive function in 395 healthy controls
and 438 patients with chronic schizophrenia on long-term treatments with
antipsychotics, including mainly monotherapy with clozapine (n=224),
risperidone (n=99) and typical antipsychotics (n=115).
Results: Cognitive test scores were significantly lower in all patient
groups than healthy controls on all scales (all p<0.001) except for visuos-
pitial/constructional index. Clozapine treatment had significantly lower
immediate memory and delayed memory than typical antipsychotics
(all p<0.01). Clozapine treatment had better language index than risperi-
done (p<0.01).
Conclusion: Patients with chronic schizophrenia performed significant
cognitive deficits than healthy controls in all examined cognitive domains
except for the visuospitial/constructional index. Cognitive deficits in
patients with chronic schizophrenia were significantly influenced by dif-
ferent type’s antipsychotics treatment. Clozapine treatment had worse im-
mediate memory and delayed memory than typical antipsychotics, and
better language performance than risperidone.
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